Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Racial differences in mycosis fungoides: a retrospective study with a focus on eosinophilia.

Zampella JG, Hinds GA.

J Am Acad Dermatol. 2013 Jun;68(6):967-71. doi: 10.1016/j.jaad.2012.11.021. Epub 2013 Jan 29.

PMID:
23374234
2.

Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.

Sun G, Berthelot C, Li Y, Glass DA 2nd, George D, Pandya A, Kurzrock R, Duvic M.

J Am Acad Dermatol. 2009 Feb;60(2):231-5. doi: 10.1016/j.jaad.2008.09.063. Epub 2008 Nov 20.

PMID:
19026464
3.

Early-onset mycosis fungoides among African American women: a single-institution study.

Balagula Y, Dusza SW, Zampella J, Sweren R, Hinds GA.

J Am Acad Dermatol. 2014 Sep;71(3):597-8. doi: 10.1016/j.jaad.2014.05.005. No abstract available.

PMID:
25128117
4.

Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008.

Nath SK, Yu JB, Wilson LD.

Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):419-23. doi: 10.1016/j.clml.2013.12.018. Epub 2014 Jan 3.

5.

Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database.

Su C, Nguyen KA, Bai HX, Cao Y, Tao Y, Xiao R, Karakousis G, Zhang PJ, Zhang G.

J Am Acad Dermatol. 2017 Sep;77(3):497-502.e2. doi: 10.1016/j.jaad.2017.04.1137. Epub 2017 Jun 20.

PMID:
28645647
6.
7.

Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.

Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.

Br J Dermatol. 2006 Oct;155(4):756-62.

PMID:
16965425
8.

Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991-2006.

Alsaleh QA, Nanda A, Al-Ajmi H, Al-Sabah H, Elkashlan M, Al-Shemmari S, Demierre MF.

Int J Dermatol. 2010 Dec;49(12):1393-8.

PMID:
21155090
9.

Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex.

Hinds GA, Alhariri J, Klein RQ, Wilson LD.

Am J Clin Oncol. 2013 Oct;36(5):481-5. doi: 10.1097/COC.0b013e31825494d3.

PMID:
22706179
10.

Profile of mycosis fungoides in 43 Saudi patients.

AlGhamdi KM, Arafah MM, Al-Mubarak LA, Khachemoune A, Al-Saif FM.

Ann Saudi Med. 2012 May-Jun;32(3):283-7. doi: 10.5144/0256-4947.2012.283.

11.

Determinants of black/white differences in colon cancer survival.

Mayberry RM, Coates RJ, Hill HA, Click LA, Chen VW, Austin DF, Redmond CK, Fenoglio-Preiser CM, Hunter CP, Haynes MA, et al.

J Natl Cancer Inst. 1995 Nov 15;87(22):1686-93.

PMID:
7473817
12.

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups.

Sausville EA, Eddy JL, Makuch RW, Fischmann AB, Schechter GP, Matthews M, Glatstein E, Ihde DC, Kaye F, Veach SR, et al.

Ann Intern Med. 1988 Sep 1;109(5):372-82.

PMID:
3408055
13.

Eosinophils in mycosis fungoides: an uncommon finding in the patch and plaque stages.

Dalton SR, Chandler WM, Abuzeid M, Hossler EW, Ferringer T, Elston DM, LeBoit PE.

Am J Dermatopathol. 2012 Aug;34(6):586-91. doi: 10.1097/DAD.0b013e31823d921b.

PMID:
22814317
14.

Racial differences in survival after surgical treatment for melanoma.

Collins KK, Fields RC, Baptiste D, Liu Y, Moley J, Jeffe DB.

Ann Surg Oncol. 2011 Oct;18(10):2925-36. doi: 10.1245/s10434-011-1706-3. Epub 2011 Apr 9.

15.

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.

Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.

Arch Dermatol. 2003 Jul;139(7):857-66.

PMID:
12873880
16.

Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.

Diamandidou E, Colome-Grimmer M, Fayad L, Duvic M, Kurzrock R.

Blood. 1998 Aug 15;92(4):1150-9.

17.
18.

Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.

Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, Narinski N, Safirman S, Maron M, Klein K.

Br J Dermatol. 2001 Dec;145(6):974-80.

PMID:
11899152
20.

Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.

J Clin Oncol. 2010 Nov 1;28(31):4730-9. doi: 10.1200/JCO.2009.27.7665. Epub 2010 Sep 20.

PMID:
20855822

Supplemental Content

Support Center